These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16715384)

  • 41. Dispersibility of lactose fines as compared to API in dry powders for inhalation.
    Thalberg K; Åslund S; Skogevall M; Andersson P
    Int J Pharm; 2016 May; 504(1-2):27-38. PubMed ID: 26965200
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of drug alone and carrier-based GLP-1 dry powder inhaler formulations.
    Babenko M; Alany RG; Calabrese G; Kaialy W; ElShaer A
    Int J Pharm; 2022 Apr; 617():121601. PubMed ID: 35181460
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Optimization of a spray drying process to prepare dry powder microparticles containing plasmid nanocomplex.
    Mohajel N; Najafabadi AR; Azadmanesh K; Vatanara A; Moazeni E; Rahimi A; Gilani K
    Int J Pharm; 2012 Feb; 423(2):577-85. PubMed ID: 22101289
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The influence of lactose carrier on the content homogeneity and dispersibility of beclomethasone dipropionate from dry powder aerosols.
    Zeng XM; Pandhal KH; Martin GP
    Int J Pharm; 2000 Mar; 197(1-2):41-52. PubMed ID: 10704792
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Co-spray dried hydrophobic drug formulations with crystalline lactose for inhalation aerosol delivery.
    Ke WR; Kwok PCL; Khanal D; Chang RYK; Chan HK
    Int J Pharm; 2021 Jun; 602():120608. PubMed ID: 33862136
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of a novel dry powder inhalation formulation for the delivery of rivastigmine hydrogen tartrate.
    Simon A; Amaro MI; Cabral LM; Healy AM; de Sousa VP
    Int J Pharm; 2016 Mar; 501(1-2):124-38. PubMed ID: 26836711
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aerosolization characteristics of dry powder inhaler formulations for the excipient enhanced growth (EEG) application: effect of spray drying process conditions on aerosol performance.
    Son YJ; Worth Longest P; Hindle M
    Int J Pharm; 2013 Feb; 443(1-2):137-45. PubMed ID: 23313343
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Spray-dried powders for pulmonary drug delivery.
    Seville PC; Li HY; Learoyd TP
    Crit Rev Ther Drug Carrier Syst; 2007; 24(4):307-60. PubMed ID: 18197788
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization and aerodynamic evaluation of spray dried recombinant human growth hormone using protein stabilizing agents.
    Jalalipour M; Gilani K; Tajerzadeh H; Najafabadi AR; Barghi M
    Int J Pharm; 2008 Mar; 352(1-2):209-16. PubMed ID: 18164150
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of metal salts on aerosol performance of spray dried carrier-free formulations of levofloxacin.
    Barazesh A; Gilani K; Rouini M; Barghi MA
    Daru; 2020 Jun; 28(1):75-85. PubMed ID: 31808069
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Feasibility of spray drying bacteriophages into respirable powders to combat pulmonary bacterial infections.
    Vandenheuvel D; Singh A; Vandersteegen K; Klumpp J; Lavigne R; Van den Mooter G
    Eur J Pharm Biopharm; 2013 Aug; 84(3):578-82. PubMed ID: 23353012
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel Budesonide Particles for Dry Powder Inhalation Prepared Using a Microfluidic Reactor Coupled With Ultrasonic Spray Freeze Drying.
    Saboti D; Maver U; Chan HK; Planinšek O
    J Pharm Sci; 2017 Jul; 106(7):1881-1888. PubMed ID: 28285981
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of water to ethanol feed ratio on physical properties and aerosolization behavior of spray dried cromolyn sodium particles.
    Gilani K; Najafabadi AR; Barghi M; Rafiee-Tehrani M
    J Pharm Sci; 2005 May; 94(5):1048-59. PubMed ID: 15793812
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preparation of honokiol-loaded chitosan microparticles via spray-drying method intended for pulmonary delivery.
    Li X; Guo Q; Zheng X; Kong X; Shi S; Chen L; Zhao X; Wei Y; Qian Z
    Drug Deliv; 2009 Apr; 16(3):160-6. PubMed ID: 19514976
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sustained delivery by leucine-modified chitosan spray-dried respirable powders.
    Learoyd TP; Burrows JL; French E; Seville PC
    Int J Pharm; 2009 May; 372(1-2):97-104. PubMed ID: 19429272
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Engineering hydrophobically modified chitosan for enhancing the dispersion of respirable microparticles of levofloxacin.
    Merchant Z; Taylor KM; Stapleton P; Razak SA; Kunda N; Alfagih I; Sheikh K; Saleem IY; Somavarapu S
    Eur J Pharm Biopharm; 2014 Nov; 88(3):816-29. PubMed ID: 25305582
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Leucine enhances the dispersibility of trehalose-containing spray-dried powders on exposure to a high-humidity environment.
    Wang Z; Wang H; Vehring R
    Int J Pharm; 2021 May; 601():120561. PubMed ID: 33811968
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Investigation of breakage behavior and its effects on spray-dried agglomerated whey protein-lactose powders: Effect of protein and lactose contents.
    Han J; Fitzpatrick J; Cronin K; Maidannyk V; Miao S
    J Dairy Sci; 2022 Nov; 105(11):8750-8764. PubMed ID: 36153160
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design, physicochemical characterization, and optimization of organic solution advanced spray-dried inhalable dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylethanolamine poly(ethylene glycol) (DPPE-PEG) microparticles and nanoparticles for targeted respiratory nanomedicine delivery as dry powder inhalation aerosols.
    Meenach SA; Vogt FG; Anderson KW; Hilt JZ; McGarry RC; Mansour HM
    Int J Nanomedicine; 2013; 8():275-93. PubMed ID: 23355776
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aerosolisation of beclomethasone dipropionate using spray dried lactose/polyethylene glycol carriers.
    Gilani K; Rouholamini Najafabadi A; Barghi M; Rafiee-Tehrani M
    Eur J Pharm Biopharm; 2004 Nov; 58(3):595-606. PubMed ID: 15451534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.